March 26, 2024

Exact Sciences Explains: BLUE-C

The BLUE-C clinical trial is one of the largest colorectal cancer screening trials ever conducted. Designed to evaluate the performance of the next-generation Cologuard® test, the study produced results demonstrating a new performance standard in non-invasive colorectal cancer detection.

Learn more:

The next-generation Cologuard test is not commercially available and has not been cleared or approved by the US Food and Drug Administration (FDA) or any other national regulatory authority.